1. Medtech Insight
  2. >>Policy & Regulation

CDRH Staff Credits Advocacy Groups For Patient Preference Guidance

Top CDRH officials say while they have been working to incorporate patient preference into their regulatory process, it was the push from patients to get more involved in the agency's decision making process that led the agency to develop a new draft guidance on the topic.

FDA officials say the persistence of patient groups and CDRH director Jeffrey Shuren's support pushed the agency to incorporate patient views into their review process.

Kathryn O'Callaghan, acting associate director for Science and Strategic Partnerships at CDRH, says the agency has been working to consider...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation